ENvue Medical , Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement and therapeutic technologies, today announced that it has resumed commercial shipments of PainShield®, manufactured in the United States, and has begun fulfilling open orders from Ultra Pain Products, Inc. ("UPPI"), the Company’s exclusive U.S. distribution partner for the product.

The resumption of shipments marks an important commercial and operational milestone following the transfer of NanoVibronix manufacturing operations from Israel to the United States. With U.S. production now operational, the Company is restoring commercial supply of PainShield and fulfilling existing distributor orders.